325 related articles for article (PubMed ID: 15959563)
1. Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger.
Ballestar E; Esteller M
Biochem Cell Biol; 2005 Jun; 83(3):374-84. PubMed ID: 15959563
[TBL] [Abstract][Full Text] [Related]
2. MeCP2 and other methyl-CpG binding proteins.
Jørgensen HF; Bird A
Ment Retard Dev Disabil Res Rev; 2002; 8(2):87-93. PubMed ID: 12112733
[TBL] [Abstract][Full Text] [Related]
3. Methyl-CpG binding proteins in the nervous system.
Fan G; Hutnick L
Cell Res; 2005 Apr; 15(4):255-61. PubMed ID: 15857580
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.
Stirzaker C; Song JZ; Davidson B; Clark SJ
Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996
[TBL] [Abstract][Full Text] [Related]
5. Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer.
Ballestar E; Paz MF; Valle L; Wei S; Fraga MF; Espada J; Cigudosa JC; Huang TH; Esteller M
EMBO J; 2003 Dec; 22(23):6335-45. PubMed ID: 14633992
[TBL] [Abstract][Full Text] [Related]
6. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis.
Saito Y; Kanai Y; Sakamoto M; Saito H; Ishii H; Hirohashi S
Hepatology; 2001 Mar; 33(3):561-8. PubMed ID: 11230735
[TBL] [Abstract][Full Text] [Related]
7. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.
Esteller M
Oncogene; 2002 Aug; 21(35):5427-40. PubMed ID: 12154405
[TBL] [Abstract][Full Text] [Related]
8. Methyl CpG-binding proteins and transcriptional repression.
Wade PA
Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and Rett syndrome.
Kriaucionis S; Bird A
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R221-7. PubMed ID: 12928486
[TBL] [Abstract][Full Text] [Related]
10. [Recognition of methylated DNA].
Shirakawa M; Ohki I
Tanpakushitsu Kakusan Koso; 2002 Aug; 47(10):1268-75. PubMed ID: 12184065
[No Abstract] [Full Text] [Related]
11. Methyl-CpG binding proteins and cancer: are MeCpGs more important than MBDs?
Prokhortchouk E; Hendrich B
Oncogene; 2002 Aug; 21(35):5394-9. PubMed ID: 12154402
[No Abstract] [Full Text] [Related]
12. MeCP2: the chromatin connection and beyond.
Zlatanova J
Biochem Cell Biol; 2005 Jun; 83(3):251-62. PubMed ID: 15959553
[TBL] [Abstract][Full Text] [Related]
13. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver.
Esfandiari F; Green R; Cotterman RF; Pogribny IP; James SJ; Miller JW
Carcinogenesis; 2003 Dec; 24(12):1935-40. PubMed ID: 12949043
[TBL] [Abstract][Full Text] [Related]
14. Altered methylation pattern of the G6 PD promoter in Rett syndrome.
Huppke P; Bohlander S; Krämer N; Laccone F; Hanefeld F
Neuropediatrics; 2002 Apr; 33(2):105-8. PubMed ID: 12075494
[TBL] [Abstract][Full Text] [Related]
15. [How the methyl-CpG binding protein-related epigenetic disease turns on the genes that produce its symptoms].
Horike S
Tanpakushitsu Kakusan Koso; 2005 Jul; 50(8):978-84. PubMed ID: 16001803
[No Abstract] [Full Text] [Related]
16. A profile of methyl-CpG binding domain protein occupancy of hypermethylated promoter CpG islands of tumor suppressor genes in human cancer.
Lopez-Serra L; Ballestar E; Fraga MF; Alaminos M; Setien F; Esteller M
Cancer Res; 2006 Sep; 66(17):8342-6. PubMed ID: 16951140
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
Wischnewski F; Friese O; Pantel K; Schwarzenbach H
Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker.
Teodoridis JM; Strathdee G; Brown R
Drug Resist Updat; 2004; 7(4-5):267-78. PubMed ID: 15533764
[TBL] [Abstract][Full Text] [Related]
20. Tight interaction between densely methylated DNA fragments and the methyl-CpG binding domain of the rat MeCP2 protein attached to a solid support.
Shiraishi M; Sekiguchi A; Chuu YH; Sekiya T
Biol Chem; 1999 Sep; 380(9):1127-31. PubMed ID: 10543452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
